Jonathan Brett Orens MD
Critical Care Medicine
Professor of Medicine, Johns Hopkins University School of Medicine; Vice Chairman for Clinical Business Development-Department of Medicine Division of Pulmonary and Critical Care Medicine
Join to View Full Profile
601 North Caroline StreetBaltimore, MD 21287
Phone+1 410-614-4898
Fax+1 410-614-7008
Dr. Orens is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of MichiganFellowship, Pulmonary Disease and Critical Care Medicine, 1991 - 1994
University of MarylandResidency, Internal Medicine, 1987 - 1991
University of Maryland School of MedicineClass of 1987
Certifications & Licensure
MD State Medical License 1988 - 2025
MI State Medical License 1991 - 1995
American Board of Internal Medicine Critical Care Medicine- American Board of Internal Medicine Pulmonary Disease
National Board of Physicians and Surgeons Critical Care Medicine- National Board of Physicians and Surgeons Internal Medicine
- National Board of Physicians and Surgeons Pulmonary Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Clinical Trials
- Genome Transplant Dynamics Start of enrollment: 2015 Jun 25
Roles: Contact
Publications & Presentations
PubMed
- Molecular criteria for pulmonary antibody-mediated rejection are associated with an increased risk of allograft failure.Michael B Keller, David Newman, Muhtadi Alnababteh, Ann Bon, Lucia Ponor
The Journal of Heart and Lung Transplantation. 2025-03-20 - breast implant infection in a lung transplant recipient.Ashley Barnes, Kristen Broderick, Errol Bush, Jonathan Orens, Melanie Marashly
JHLT Open. 2025-02-01 - 1 citationsExtreme elevations of donor-derived cell-free DNA increases the risk of chronic lung allograft dysfunction and death, even without clinical manifestations of disease.Michael B Keller, David Newman, Muhtadi Alnababteh, Lucia Ponor, Pali Shah
The Journal of Heart and Lung Transplantation. 2024-09-01
Press Mentions
Covid Disease Damage Leading to 'Completely New Category' of Organ TransplantsApril 12th, 2021- Convalescent Plasma Used to Prevent Spread of COVID-19October 20th, 2020
External Links
- Johns Hopkins Physicianshttp://www.hopkinsmedicine.org/jonathan-orens
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
